Symptoms and Endoscopic Results in Consideration of Pretreatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00612404|
Recruitment Status : Completed
First Posted : February 11, 2008
Last Update Posted : February 11, 2008
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||16255 participants|
|Official Title:||Symptoms and Endoscopic Results in Consideration of Pretreatment|
|Study Start Date :||September 2005|
|Actual Primary Completion Date :||December 2005|
patients with gastrointestinal disorders who need an endoscopy.
- to gain insight into the relationship between subjective gastrointestinal symptoms and findings of a laryngopharyngeal-esophagogastric endoscopy with respect to the medicinal pre-therapy;
- to gain insight into the currently used treatment strategies with esomeprazole depending on endoscopic findings.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00612404
|Study Chair:||Kai Richter, MD||Medical Department AstraZeneca Germany|